Clinical trial
A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors
NCT00030173 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00030173 |
|---|---|
| Title | A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors |
| Official title | A Phase 1, Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Epothilone D in Patients With Advanced Solid Tumors |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | Epothilone D (KOS-862) |
| Enrollment | 45 |
| Start date | Oct 1, 2001 |
| Completion | Jun 1, 2003 |
| First posted | Feb 8, 2002 |
| Last update posted | Jan 8, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: